Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sharmilan Thanendrarajan

Concepts (239)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
60
2025
2990
4.110
Why?
Antibodies, Bispecific
6
2025
88
1.170
Why?
Hematopoietic Stem Cell Transplantation
9
2024
580
1.080
Why?
Leukemia, Plasma Cell
2
2020
32
0.850
Why?
Immunotherapy, Adoptive
5
2024
161
0.710
Why?
Bone Marrow
10
2022
360
0.680
Why?
B-Cell Maturation Antigen
7
2025
98
0.670
Why?
Neoplasms, Plasma Cell
3
2024
36
0.630
Why?
Humans
69
2025
50419
0.590
Why?
Plasma Cells
6
2023
220
0.580
Why?
Chromosome Deletion
2
2023
134
0.570
Why?
Transplantation, Autologous
10
2024
480
0.560
Why?
Chromosomes, Human, Pair 17
1
2017
34
0.550
Why?
Gene Expression Profiling
10
2023
1020
0.530
Why?
Tumor Suppressor Protein p53
2
2017
212
0.520
Why?
Clinical Trials as Topic
4
2022
488
0.510
Why?
Gene Expression Regulation, Neoplastic
6
2021
831
0.500
Why?
Neoplasm, Residual
6
2022
161
0.480
Why?
Proteasome Inhibitors
1
2016
104
0.470
Why?
Immunologic Factors
1
2016
113
0.470
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2024
112
0.470
Why?
Aged
23
2025
9738
0.440
Why?
Prognosis
15
2024
1974
0.440
Why?
Immunotherapy
1
2016
234
0.440
Why?
Translocation, Genetic
5
2021
236
0.430
Why?
Stem Cell Transplantation
5
2024
179
0.430
Why?
Mutation
7
2022
1275
0.420
Why?
Antibodies, Monoclonal
2
2022
460
0.420
Why?
Neoplasm Proteins
4
2020
320
0.390
Why?
Neutropenia
2
2023
116
0.380
Why?
Survival Analysis
8
2024
658
0.380
Why?
Neoplasms
2
2012
1248
0.370
Why?
Cytokine-Induced Killer Cells
1
2011
2
0.370
Why?
Lymphocytes
1
2012
153
0.360
Why?
Evolution, Molecular
2
2021
86
0.350
Why?
Cancer Vaccines
1
2011
80
0.340
Why?
Neoplasm Recurrence, Local
7
2024
622
0.340
Why?
Positron-Emission Tomography
4
2022
290
0.340
Why?
Diffusion Magnetic Resonance Imaging
3
2019
124
0.320
Why?
Cytokines
1
2012
602
0.310
Why?
Tumor Microenvironment
3
2024
221
0.290
Why?
Female
27
2025
27053
0.290
Why?
Middle Aged
21
2025
12579
0.290
Why?
Aged, 80 and over
9
2025
3233
0.290
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2024
997
0.290
Why?
Hematologic Neoplasms
2
2022
99
0.280
Why?
Combined Modality Therapy
4
2024
640
0.270
Why?
Atrial Fibrillation
2
2022
188
0.270
Why?
Male
25
2025
25866
0.250
Why?
Adult
17
2025
13561
0.240
Why?
Fluorodeoxyglucose F18
4
2021
187
0.230
Why?
Proto-Oncogene Proteins B-raf
3
2020
80
0.230
Why?
Immunoglobulins, Intravenous
1
2025
64
0.230
Why?
Polycomb Repressive Complex 2
2
2021
46
0.230
Why?
Neoplasms, Second Primary
1
2024
74
0.210
Why?
Treatment Outcome
8
2024
5265
0.210
Why?
Chromosomes, Human, Pair 1
2
2023
92
0.200
Why?
Risk Factors
9
2024
3712
0.200
Why?
Disease Progression
6
2021
825
0.200
Why?
Paraproteinemias
1
2022
71
0.190
Why?
Immunoconjugates
1
2022
37
0.190
Why?
Osteolysis
1
2022
74
0.190
Why?
Drug Approval
1
2022
47
0.190
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.190
Why?
Lymphoma, B-Cell
1
2022
49
0.190
Why?
Recurrence
6
2024
657
0.190
Why?
Epigenomics
1
2021
65
0.180
Why?
Patient Participation
1
2022
73
0.180
Why?
T-Lymphocytes
4
2024
325
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.170
Why?
Cell Cycle
1
2021
227
0.170
Why?
Practice Guidelines as Topic
1
2023
473
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Bone Resorption
1
2022
301
0.170
Why?
Retrospective Studies
8
2025
6274
0.160
Why?
Bone Diseases
1
2021
96
0.160
Why?
Gene Regulatory Networks
1
2020
106
0.160
Why?
Chromosomal Instability
1
2019
16
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
Why?
Disease-Free Survival
5
2019
439
0.160
Why?
Antigens, CD
1
2020
221
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.150
Why?
Healthcare Disparities
1
2022
280
0.150
Why?
Spleen
1
2019
169
0.150
Why?
Spinal Fractures
1
2018
38
0.150
Why?
Phosphotransferases
1
2018
16
0.150
Why?
Antineoplastic Agents
2
2024
1165
0.150
Why?
Brain Neoplasms
2
2011
281
0.150
Why?
Bacteremia
1
2019
89
0.140
Why?
Adipocytes
1
2018
126
0.140
Why?
Gene Rearrangement
1
2018
63
0.140
Why?
Hexokinase
1
2017
17
0.140
Why?
Retinoblastoma Binding Proteins
1
2017
11
0.140
Why?
Epigenesis, Genetic
1
2020
371
0.140
Why?
Calcification, Physiologic
1
2017
40
0.130
Why?
Pelvis
1
2017
66
0.130
Why?
Cell Proliferation
4
2023
980
0.130
Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
90
0.130
Why?
Survival Rate
4
2020
906
0.130
Why?
Immunoglobulin Light Chains
1
2017
83
0.130
Why?
Ubiquitin-Protein Ligases
1
2017
93
0.130
Why?
Flow Cytometry
1
2018
472
0.130
Why?
Clonal Evolution
1
2016
56
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
178
0.130
Why?
Gene Expression
1
2018
605
0.120
Why?
Animals
4
2024
13063
0.110
Why?
Cystatin M
2
2024
19
0.110
Why?
Cross-Sectional Studies
3
2023
1601
0.100
Why?
Cardiovascular Diseases
1
2017
464
0.100
Why?
Follow-Up Studies
3
2024
2231
0.090
Why?
Lymphoma, Non-Hodgkin
1
2011
55
0.090
Why?
Astrocytoma
1
2011
21
0.090
Why?
Disease Models, Animal
1
2016
1431
0.090
Why?
Mutation Rate
2
2021
35
0.090
Why?
Glioma
1
2011
74
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
231
0.090
Why?
Genomics
2
2023
238
0.080
Why?
Alleles
2
2021
252
0.080
Why?
Remission Induction
2
2021
208
0.080
Why?
Tumor Burden
2
2020
130
0.080
Why?
Proto-Oncogene Proteins p21(ras)
2
2021
67
0.080
Why?
Histones
2
2021
294
0.080
Why?
Vaccination
1
2011
275
0.080
Why?
Transcription Factors
2
2023
561
0.080
Why?
DNA Copy Number Variations
2
2021
109
0.070
Why?
Radiopharmaceuticals
2
2021
202
0.070
Why?
Models, Biological
1
2011
717
0.070
Why?
Cell Differentiation
2
2022
640
0.070
Why?
Transcriptome
2
2020
314
0.070
Why?
Kaplan-Meier Estimate
2
2019
462
0.070
Why?
Imaging, Three-Dimensional
2
2017
151
0.060
Why?
Biopsy
2
2018
588
0.060
Why?
Arkansas
2
2021
1974
0.060
Why?
Ferritins
1
2024
30
0.050
Why?
Killer Cells, Natural
1
2024
107
0.050
Why?
Demography
1
2024
93
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
X-Ray Microtomography
1
2024
78
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
127
0.050
Why?
Receptors, G-Protein-Coupled
1
2024
49
0.050
Why?
Mice
2
2024
5659
0.050
Why?
Antibodies
1
2024
151
0.050
Why?
Signal Transduction
2
2021
1608
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
49
0.050
Why?
Geography
1
2022
60
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
32
0.050
Why?
Patient Selection
1
2023
257
0.050
Why?
United States Food and Drug Administration
1
2022
91
0.050
Why?
Phylogeny
1
2022
195
0.050
Why?
Oncogenes
1
2021
54
0.050
Why?
Chromosome Aberrations
1
2023
279
0.050
Why?
Dexamethasone
1
2024
431
0.050
Why?
Bone Marrow Transplantation
1
2022
135
0.050
Why?
Syndecan-1
1
2021
73
0.050
Why?
RANK Ligand
1
2022
186
0.050
Why?
SOXC Transcription Factors
1
2021
13
0.050
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
82
0.040
Why?
Chromatin
1
2021
133
0.040
Why?
Transcriptional Activation
1
2021
120
0.040
Why?
Clone Cells
1
2021
72
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2022
224
0.040
Why?
Pyrimidines
1
2022
187
0.040
Why?
Cyclin D2
1
2020
20
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
49
0.040
Why?
Histone Code
1
2020
30
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
29
0.040
Why?
Cyclin D1
1
2020
52
0.040
Why?
ras Proteins
1
2020
65
0.040
Why?
Genome, Human
1
2021
108
0.040
Why?
Protein Kinase Inhibitors
1
2022
204
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
66
0.040
Why?
DNA, Neoplasm
1
2020
144
0.040
Why?
Genetic Variation
1
2020
197
0.040
Why?
Health Status Disparities
1
2022
201
0.040
Why?
DNA Mutational Analysis
1
2020
175
0.040
Why?
Cell Line, Tumor
1
2023
1393
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
162
0.040
Why?
Osteoclasts
1
2022
427
0.040
Why?
Multivariate Analysis
1
2021
583
0.040
Why?
Computational Biology
1
2020
194
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
26
0.040
Why?
Pseudomonas Infections
1
2019
49
0.040
Why?
Syndrome
1
2019
236
0.040
Why?
Fractures, Compression
1
2018
17
0.040
Why?
DNA-Binding Proteins
1
2021
410
0.040
Why?
Promoter Regions, Genetic
1
2020
455
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
46
0.040
Why?
Oncogene Proteins, Fusion
1
2018
57
0.040
Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
8
0.040
Why?
Protein-Tyrosine Kinases
1
2018
85
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
27
0.040
Why?
Kidney Function Tests
1
2017
52
0.030
Why?
STAT3 Transcription Factor
1
2017
77
0.030
Why?
False Positive Reactions
1
2017
59
0.030
Why?
Retinoblastoma Protein
1
2017
19
0.030
Why?
Fibroblast Growth Factors
1
2017
46
0.030
Why?
Bone and Bones
1
2021
481
0.030
Why?
Glomerular Filtration Rate
1
2017
119
0.030
Why?
Mitogen-Activated Protein Kinases
1
2017
154
0.030
Why?
Amino Acid Sequence
1
2018
575
0.030
Why?
Sequence Analysis, DNA
1
2017
194
0.030
Why?
Alkaline Phosphatase
1
2017
94
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
NF-kappa B
1
2018
306
0.030
Why?
Genes, p53
1
2016
49
0.030
Why?
Glycolysis
1
2016
69
0.030
Why?
DNA Methylation
1
2020
548
0.030
Why?
Models, Genetic
1
2016
166
0.030
Why?
Genomic Instability
1
2016
90
0.030
Why?
Staphylococcal Infections
1
2019
267
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
105
0.030
Why?
Logistic Models
1
2018
901
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
139
0.030
Why?
Melphalan
1
2016
177
0.030
Why?
Heart
1
2017
341
0.030
Why?
Kidney Diseases
1
2017
213
0.030
Why?
Algorithms
1
2018
624
0.030
Why?
Echocardiography
1
2017
398
0.030
Why?
Time Factors
1
2021
2933
0.030
Why?
Myocardium
1
2017
443
0.030
Why?
Thalidomide
1
2016
375
0.030
Why?
Disease Management
1
2015
179
0.030
Why?
Longitudinal Studies
1
2016
732
0.030
Why?
Risk Assessment
1
2018
1268
0.030
Why?
Dose-Response Relationship, Drug
1
2016
1369
0.030
Why?
Ifosfamide
1
2011
11
0.020
Why?
Dacarbazine
1
2011
10
0.020
Why?
Tomography, X-Ray Computed
1
2017
1163
0.020
Why?
Carboplatin
1
2011
54
0.020
Why?
Etoposide
1
2011
77
0.020
Why?
United States
1
2022
5005
0.020
Why?
Fatal Outcome
1
2011
197
0.020
Why?
Treatment Failure
1
2011
120
0.020
Why?
Drug Administration Schedule
1
2011
373
0.020
Why?
Magnetic Resonance Imaging
1
2017
1546
0.020
Why?
Thanendrarajan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description